Safety and efficacy of a combined oral contraceptive: Gestodene 75 μg plus ethinyl estradiol 30 μg in Mexican women-Reference-Cited by-同舟云学术

Safety and efficacy of a combined oral contraceptive: Gestodene 75 μg plus ethinyl estradiol 30 μg in Mexican women

Published:1994-03 Issue:1 Volume:10 Page:19-26
ISSN:0267-4874
Container-title:Advances in Contraception
language:en
Short-container-title:Adv Contracept

Author:

Garza-Flores J.,de Bourges V. Valles,Martínez M.,Vázquez-Estrada L.,Bassol S.,Recio R.,Pérez-Palacios G.

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology

Link

http://link.springer.com/content/pdf/10.1007/BF01986525.pdf

Reference19 articles.

1. Garza-Flores J, Martínez M, Díaz L, Pérez-Placios G. Risks and benefits of hormonal contraception. Oficina Sanitaria Panamericana; 1993.

2. Hofmeister H, Annen K, Laurent H, Petzoldt K, Wiechert R. Synthesen von Gestodene. Arzneim-Foresch Drug Res. 1986;36:781–3.

3. Schering AG. Pharmacokinetic data on file.

4. Spona J, Huber J. Pharmacological and endocrine profiles of gestodene. Int J Fertil (suppl). 1987;32:6–14.

5. Spona J, Huber J. Inhibition of ovulation with gestodene. Gestodene: Proceedings of a special satellite symposium held in conjunction with the XI World Congress of Gynecology and Obstetrics. Carnforth: Parthenon Publishing Group; 1987:45–54.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hormonal Contraception and Physiology: A Research-based Theory of Discontinuation Due to Side Effects;Studies in Family Planning;2005-03

2. A prospective open-label study to evaluate the effects of the oral contraceptive Harmonet® (gestodene75/EE20) on body fat;Contraception;2004-07

3. The effects of a low-dose gestodene-containing oral contraceptive on endometrial histology in healthy women;The European Journal of Contraception & Reproductive Health Care;1996-01